In GBM, FAP expression was found in both tumor cells and stromal components, including mesenchymal cells and pericytes surrounding the vascular network; therefore, FAP is considered to be a potential therapeutic target for strategies aiming to destroy tumor cells, their supporting vascular networks and extracellular matrix integrity. The gene discussed is FAP; the disease is neoplasm.